(Q79635016)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245595%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

title

HER-2/neu status and response to CMF: retrospective study in a series of operable breast cancer treated with primary CMF chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245595%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245595%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

Catalina Falo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245595%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Abelardo Moreno

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245595%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Belen Lloveras

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245595%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Agnès Figueras

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245595%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Agustín Escobedo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245595%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

24 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245595%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cancer Research and Clinical Oncology

24 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245595%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

133

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245595%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245595%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

423-429

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245595%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00432-006-0176-7

24 December 2019

exact match

0 references

cites work

Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer

1 reference

12 December 2020

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

12 December 2020

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer

1 reference

12 December 2020

Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer

1 reference

12 December 2020

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

1 reference

12 December 2020

Primary chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil in operable breast carcinoma

1 reference

12 December 2020

Her-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancer

1 reference

12 December 2020

Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute

1 reference

12 December 2020

HER2 overexpression and paclitaxel sensitivity in breast cancer: therapeutic implications

1 reference

12 December 2020

HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15

1 reference

12 December 2020

Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy.

1 reference

12 December 2020

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

12 December 2020

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

12 December 2020

Adjuvant docetaxel for node-positive breast cancer

1 reference

12 December 2020

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

12 December 2020

Effect of c-erbB(2) and estrogen receptor status on survival of women with primary breast cancer treated with adjuvant cyclophosphamide/methotrexate/fluorouracil

1 reference

12 December 2020

ErbB2 overexpression in human breast carcinoma is correlated with p21Cip1 up-regulation and tyrosine-15 hyperphosphorylation of p34Cdc2: poor responsiveness to chemotherapy with cyclophoshamide methotrexate, and 5-fluorouracil is associated with Erb

1 reference

12 December 2020

Pathologic changes related to CMF primary chemotherapy in breast cancer. Pathological evaluation of response predicts clinical outcome

1 reference

12 December 2020

Ductal carcinoma in situ of the breast: correlation between histologic classifications and biologic markers

1 reference

12 December 2020

Algorithm for the diagnosis of HER-2/neu status in breast-infiltrating carcinomas

1 reference

12 December 2020

The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years

1 reference

12 December 2020

Evaluation of HER-2 neu oncoprotein expression as a prognostic indicator of local recurrence in conservatively treated breast cancer: a case-control study

1 reference

12 December 2020

The neu oncogene encodes an epidermal growth factor receptor-related protein

1 reference

12 December 2020

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma

1 reference

12 December 2020

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

1 reference

12 December 2020

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

12 December 2020

Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables.

1 reference

12 December 2020

10.1007/S00432-006-0176-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245595%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference